Show Summary Details
Page of

Brucellosis 

Brucellosis
Chapter:
Brucellosis
Author(s):

J. Zinsstag

, E. Schelling

, J. Solera

, J. M. Blasco

, and I. Moriyón

DOI:
10.1093/med/9780198570028.003.0007
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 28 September 2020

Brucellosis has been successfully controlled and eliminated in a number of countries by effective, well managed vaccination and test-slaughter strategies. Their cost was essentially borne by national governments including the cost of acceptable compensation for culled animals. Brucellosis is, however, endemically persisting in livestock and causing human disease in the Mediterranean region, Africa, the Near East and Central America and is re-emerging as a major preventable disease in countries of the former Soviet Union and Mongolia. There has been significant progress in knowledge of the molecular biology of Brucellosis and with new antibiotics for the treatment of human cases. Significantly more efficacious and safe animal vaccines in terms of reduction of transmission are still lacking. Control strategies that have been successful in Western countries are not directly applicable to low income and transition countries because their national governments do not have the finance to compensate farmers and lack the technical capacity for effective control campaigns. However, new staged control approaches in developing economies are proving effective.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.